Diabetic retinopathy complications have been reported, particularly in patients with pre-existing retinopathy experiencing rapid improvements in glycaemic control
If patients do not tolerate the maintenance dosage of 2.4 mg once weekly, the dosage can be decreased to 1.7 mg once weekly
The goal is to find the sweet spot: lowest dose producing meaningful metabolic benefit with minimal GI side effects and superior long-term adherence
Monitor for symptoms such as a neck mass, difficulty swallowing, shortness of breath, or persistent hoarseness, and consult a healthcare provider if these occur
Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis
However, coverage for their weight-loss counterparts, Wegovy and Zepbound, is less consistent